NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Carrie Hersh
Cleveland Clinic - Cleveland / United States
Medical and Health Sciences / Nephrology
AD Scientific Index ID: 4473513
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Carrie Hersh's MOST POPULAR ARTICLES
1-)
Updates and advances in multiple sclerosis neurotherapeuticsM Amin, CM HershNeurodegenerative disease management 13 (1), 47-70, 2023842023
2-)
Wellness and the role of comorbidities in multiple sclerosisBP Moss, MR Rensel, CM HershNeurotherapeutics 14 (4), 999-1017, 2017832017
3-)
Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-upCM Hersh, TE Love, A Bandyopadhyay, S Cohn, C Hara-Cleaver, ...Multiple Sclerosis Journal–Experimental, Translational and Clinical 3 (3 …, 2017732017
4-)
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised …JF Foley, G Defer, LZ Ryerson, JA Cohen, DL Arnold, H Butzkueven, ...The Lancet Neurology 21 (7), 608-619, 2022722022
5-)
Harnessing real-world data to inform decision-making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)EM Mowry, RA Bermel, JR Williams, TLS Benzinger, C De Moor, E Fisher, ...Frontiers in neurology 11, 632, 2020722020
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept